About 4 results found for searched term "119-68-6" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1855 | Dabrafenib Mesylate | Raf |
| GSK-2118436B | ||
| Dabrafenib (GSK2118436) is a selective, orally bioavailable inhibitor of Mutant B-raf (BRAF) protein kinase with potential antineoplastic activity. | ||
| M20475 | Safinamide | Others |
| EMD-1195686, PNU-15774E | ||
| Safinamide is an orally active, selective, reversible |
||
| M53979 | 2-(Methylamino)benzoic acid | Metabolite/Endogenous Metabolite |
| 2-(Methylamino)benzoic acid is the main metabolite of methyl-N-methylanthranilates (MMA) and is the compound in which the ester group is converted. | ||
| M3950 | APD668 | GPR/FFAR |
| APD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively. APD668 pairs are divided by CYP2C9 (KiNone of the five major CYP subtypes other than =0.1 μM) had no significant inhibitory effect. APD668 can be used for research on steatohepatitis and diabetes. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
